17:20 uur 20-11-2017

Leiders Synteract spreken en exposeren op Partnerships in Clinical Trials Europe in Amsterdam

CRO besteedt op branche-evenement aandacht aan klantgerichte, internationale expertise

SAN DIEGO & AMSTERDAM–(BUSINESS WIRE)– (Booth #17) – Toonzettende persoonlijkheden van Synteract, een bedrijf in uitbestede onderzoeksdiensten, exposeren en presenteren op Partnerships in Clinical Trials Europe (PCT), dat van 28 tot 29 november plaatsvindt in Amsterdam. Nu er meer bewustzijn is over verschuivingen binnen de markt voor aanbieders van uitbesteed onderzoek (CRO’s) en de aanverwante complexiteit  voor biofarmaceuten bij cruciale beslissingen rond outsourcing, nodigt Synteract bezoekers uit ‘te pauzeren en na te denken over de zaken die het belangrijkst zijn voor uw CRO’.

Dr. Martine Dehlinger-Kremer, vicepresident voor internationale medische en wettelijke zaken van Synteract, geeft dinsdag 28 november om 12.00 de lezing The EU Clinical Trials Regulation: Are you prepared for its implementation?


Synteract Thought Leaders to Speak & Exhibit at Partnerships in Clinical Trials Europe in Amsterdam

CRO to highlight customer focused, international expertise at upcoming industry event

SAN DIEGO & AMSTERDAM–(BUSINESS WIRE)– (Booth #17) – Thought leaders from Synteract, a full-service, international contract research organization (CRO), will exhibit and present at Partnerships in Clinical Trials Europe (PCT), November 28-29, Amsterdam, Netherlands. With awareness of the shifting CRO landscape and the complexity this represents to biopharma companies as they make critical outsourcing decisions, Synteract invites attendees to “Pause to rethink what matters most from your CRO.”

Vice President, Global Medical and Regulatory Affairs at Synteract, Dr. Martine Dehlinger-Kremer, will speak on “The EU Clinical Trials Regulation: Are you prepared for its implementation?” at the event on Tuesday, November 28 at noon. She will address how evolving industry needs are driving momentum towards implementation of a new regulation governing clinical trials, the expected impact on sponsors and necessary steps toward preparedness.

Attendees are encouraged to stop by Booth #17 for coffee and conversation. They can also contact Trisha Vonder Reith, executive director marketing communications at trisha.vonderreith@synteract.com to set up a specific appointment time.

Visit Synteract’s full schedule of events and follow its social channels on LinkedIn and Twitter for live updates during the conference.

About Synteract

With 800 staff members across 21 countries, SynteractHCR is an international full-service contract research organization with a successful three-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in more than 60 countries, offering broad therapeutic expertise, with notable depth in oncology, immunotherapy, CNS and infectious disease, among other indications. With its “Shared Work – Shared Vision” philosophy, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data to help bring tomorrow’s treatments to patients.



for Synteract
Hilary McCarthy, 508-829-2543


Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is. Check out our twitter: @NewsNovumpr